drugset / Trial / NCT01062139

Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy

NCT01062139 ↗

Phase 4 Unknown 100 enrolled HK inno.N Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

Title of Study: A randomized, parallel, double-blind, multi-center, comparative study to evaluate the efficacy and safety of Cosalin monotherapy versus Cosalin and Xarlin combination therapy in patients with allergic rhinitis Objective of study: To exploratively evaluate superiority of combination therapy - twice-daily Cosalin Tab (Petasites hybridus CO2 extract) with once-daily Xarlin Tab (Levocetirizine HCl) - compared to monotherapy of Cosalin with allergic rhinitis subjects.

Timeline

Start
2009-10
Primary completion
2010-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cosalin Unknown 30 mg —
Subject Xarlin Unknown 5 mg —